Trial
NCT01622660
Gemcitabine and Pazopanib in Chemotherapy Naïve Patients With Advanced/Metastatic Urothelial Carcinoma Ineligible for Cisplatin-based Chemotherapy
Phase IITERMINATEDSAFETYConfidence: MEDIUM
Sponsor
Memorial Sloan Kettering Cancer Center
Collaborators
GlaxoSmithKline
Condition
Bladder Cancer
Intervention
Gemcitabine
Why stopped
Safety reasons
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2017-08-22